NICOLE LABOR: Open Payments
NPI 1598908485 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,985 in 90 payments from 10 companies in 2025. Trend: 2023 $328 · 2024 $369 · 2025 $15,985
Speaker / faculty: $12,144Food & beverage: $1,957Travel & lodging: $1,141Honoraria: $743
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 68 | $14,854 |
| Braeburn Inc. | 7 | $829 |
| Alkermes, Inc. | 3 | $65 |
| ABBVIE INC. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Orexo US, Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 2 | $33 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: SUBLOCADE, BRIXADI, VIVITROL, CAPLYTA, REXULTI, Zubsolv, VRAYLAR, ERZOFRI EXTENDED-RELEASE.
Industry payments across OH — which companies pay providers there.
